Although the group of cured individuals encompassed MB leprosy patients, knowingly with a T cell functional defect, the significant increase in their CD8+ TEF and TEM cells in response to the ML antigen (p<0.05) suggests that these subsets may play a role in protection against relapse. This evidence concerns the gene CD8A and leprosy.